Monday, March 12, 2018 6:33:49 PM
Not only was the Apotheca acquisition illegal (wasn't even registered), but we learn today that Talari and Cox took out a convertible note of $100K in their own company without disclosure, which is also illegal.
I can't wait for the filings to hit so I can see how they slip this convertible note in. Retroactively? Presently? Is the reason for the massive dilution lately because they registered Apotheca and are now converting on that $100K note? Either way, that "acquisition" closed months ago and they withheld material information that'd affect share price. When I asked Cox about this, he told me, "I can't disclose the terms, but it's because we have some interesting things going on." Ha! (Don't worry, Cox, I have the email correspondence of this) You have nothing going on, you just wanted your share price to stay propped up and not disclose the fact that you gave yourself a $100K note.
As an aside, think logically about this for a second. Apotheca is an empty, worthless subsidiary. It wasn't even a registered business up until a couple weeks ago, so it is absolutely worthless. The company that "acquired" it, is Cannabis Leaf, Inc. (PCFP), a worthless shell. If PCFP was interested in having a subsidiary, why not just create one? It's fairly easy to spin off a subsidiary, why acquire something that has absolutely no value.. and hand over shares to do so? Clearly this is a scheme to get in bed with Cox and Talari. Ah, this is just what pink CEO's do; link up their dirty pinks with each other for money laundering purposes.
So, what will the filings show? No matter how they try to finagle this, it is illegal. What I want to know is... HOW illegal?
They just made whistle blowing this thing incredibly easy.
I implore everyone, give a moment of your effort to get blatant scams like this shutdown.
https://www.sec.gov/page/sec-miami-regional-office
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM